Preemptive Dose Optimization Using Therapeutic Drug Monitoring for Biologic Therapy of Crohn's Disease: Avoiding Failure While Lowering Costs?

Dig Dis Sci. 2015 Sep;60(9):2571-3. doi: 10.1007/s10620-015-3673-1. Epub 2015 Apr 28.

Authors

Niels Vande Casteele¹, Ann Gils

Affiliation

¹ Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven - University of Leuven, Herestraat 49, PO 820, 3000, Leuven, Belgium, niels.vandecasteele@kuleuven.be.

PMID: 25917050
DOI: 10.1007/s10620-015-3673-1

No abstract available

Publication types

Editorial
Comment

MeSH terms

Algorithms*
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
Antibodies, Monoclonal / administration & dosage*
Crohn Disease / drug therapy*
Crohn Disease / economics*
Female
Humans
Male
Precision Medicine / economics*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal